Recombinant Elephas maximus Aquaporin-2 (AQP2)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Elephas maximus Aquaporin-2 (AQP2)

AQP2 is a transmembrane protein responsible for water reabsorption in renal collecting ducts, regulated by vasopressin. The recombinant version from Elephas maximus is synthesized in microbial or eukaryotic systems for structural and functional studies. Its production involves genetic engineering to ensure proper folding, solubility, and purification. Key applications include membrane reconstitution assays, trafficking studies, and drug development for water balance disorders .

Production and Expression Systems

Recombinant AQP2 is produced using diverse systems to optimize yield, purity, and functional integrity.

Expression SystemSource OrganismTagPurityApplicationsSource
E. coliElephas maximusN-terminal His>90% (SDS-PAGE)SDS-PAGE, structural studies
YeastElephas maximusN/AN/ABiochemical assays
BaculovirusElephas maximusN/AN/ALarge-scale production
Mammalian cellElephas maximusN/AN/ATrafficking and localization

Key Observations:

  • E. coli is the most frequently used system, yielding high-purity protein with a His-tag for affinity chromatography .

  • Baculovirus systems (e.g., insect cells) are employed for large-scale production but are not explicitly documented for Elephas maximus AQP2 .

  • Partial or full-length variants are available, with the latter spanning residues 1–109 in E. coli-expressed versions .

Research Applications and Findings

Recombinant AQP2 is utilized in studies to elucidate its role in water transport and disease mechanisms.

Functional Insights

  • Water Permeability: Phosphorylation at conserved serine residues (e.g., Ser-256 in human AQP2) enhances water transport activity by 2-fold in proteoliposomes . While similar studies for Elephas maximus AQP2 are absent, its structural homology suggests comparable regulation.

  • Trafficking: AQP2 translocation to the apical membrane is regulated by vasopressin-induced cAMP/PKA signaling and cytoskeletal interactions . Recombinant AQP2 is used to model these processes in vitro .

  • Disease Models: Mutants with misfolded AQP2 (e.g., R254L) cause nephrogenic diabetes insipidus (NDI) due to ER retention. Recombinant AQP2 aids in studying such trafficking defects .

Experimental Challenges

  • Partial Constructs: Truncated versions (e.g., 1–109 aa) may lack critical regulatory regions, limiting functional assays .

  • Species-Specific Variations: Structural differences between human and Elephas maximus AQP2 may influence ligand binding or phosphorylation efficacy .

Comparative Analysis with Human AQP2

While Elephas maximus AQP2 shares functional domains with human AQP2, key differences exist in expression systems and applications.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, offered as a guideline for your reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer components, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is finalized during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
AQP2; Aquaporin-2; AQP-2; ADH water channel; Aquaporin-CD; AQP-CD; Collecting duct water channel protein; WCH-CD; Water channel protein for renal collecting duct; Fragment
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-109
Protein Length
full length protein
Species
Elephas maximus (Indian elephant)
Target Names
AQP2
Target Protein Sequence
SIAFSRAVFSEFLATLLFVFFGLGSALNWPQALPSVLQIAMAFGLAIGTLVQTLGHISGAHINPAVTVACLVGCHVSFLRATFYLAAQLLGAVAGAALLHELTPPDIRG
Uniprot No.

Target Background

Function
Forms a water-specific channel in the plasma membranes of renal collecting duct cells. This high water permeability enables water movement along osmotic gradients.
Protein Families
MIP/aquaporin (TC 1.A.8) family
Subcellular Location
Apical cell membrane; Multi-pass membrane protein. Basolateral cell membrane; Multi-pass membrane protein. Cell membrane; Multi-pass membrane protein. Cytoplasmic vesicle membrane; Multi-pass membrane protein. Golgi apparatus, trans-Golgi network membrane; Multi-pass membrane protein.

Q&A

What is Aquaporin-2 (AQP2) and what is its biological significance in elephants?

Aquaporin-2 (AQP2) is a water channel protein found in cell membranes that facilitates the passage of water molecules in and out of cells. In mammals, including elephants, AQP2 plays a critical role in kidney collecting ducts where it regulates water reabsorption and urine concentration. This protein is essential for maintaining water homeostasis, particularly in large mammals like elephants that may have specialized adaptations for water conservation in their natural habitats . AQP2 functions through arginine vasopressin-dependent trafficking mechanisms that fine-tune water reabsorption from pre-urine, allowing precise regulation of final urine volume . The evolutionary conservation of aquaporins across species suggests that Elephas maximus AQP2 likely shares structural and functional similarities with human AQP2, though with potential adaptations specific to elephant physiology.

What expression systems are most effective for producing recombinant AQP2?

Based on research with human AQP2, several expression systems have proven effective for recombinant AQP2 production, with the following considerations for elephant AQP2:

  • Baculovirus/Insect Cell System: This system has demonstrated success in large-scale expression of functional recombinant human AQP2, yielding approximately 0.5 mg of pure his-tagged AQP2 per liter of bioreactor culture . The expressed protein retains its native homotetrameric structure and functional water permeability, making this system particularly suitable for structural studies .

  • Yeast Expression (Pichia pastoris): This system has been successfully used for expressing human AQP2 mutants for structural and functional characterization . The advantage of P. pastoris is its ability to perform post-translational modifications similar to mammalian cells while offering higher protein yields than mammalian expression systems.

  • Mammalian Cell Systems: These provide the most native-like post-translational modifications but typically yield lower protein quantities. They may be preferable when studying trafficking or regulatory mechanisms that depend on mammalian-specific modifications.

For Elephas maximus AQP2 specifically, the baculovirus/insect cell system would likely provide the best balance of protein yield and functional integrity for initial characterization studies, while mammalian systems might be preferred for studies exploring species-specific regulatory mechanisms.

How can we assess the functionality of recombinant Elephas maximus AQP2?

Functionality assessment of recombinant elephant AQP2 can be performed using several complementary approaches:

  • Proteoliposome Water Permeability Assay: This gold-standard method involves reconstituting purified AQP2 into liposomes containing fluorophores and measuring water flux using stop-flow spectroscopy. When liposomes are exposed to hyperosmotic solutions, the rate of fluorescence change correlates with water permeability . This approach allows direct determination of water channel activity without confounding cellular factors.

  • Xenopus Oocyte Expression System: This system can be used to determine single channel water permeability (Pf). Previous studies with human AQP2 mutants have successfully used this approach to compare relative water permeability .

  • Structural Verification: Circular dichroism (CD) spectroscopy can confirm proper protein folding by comparing spectral patterns with known functional AQP2 . Additionally, size-exclusion chromatography can verify the tetrameric assembly essential for proper AQP2 function .

  • Thermal Stability Assessment: Techniques such as nanoDSF (nano Differential Scanning Fluorimetry) can evaluate protein stability, which often correlates with functionality in membrane proteins .

A comprehensive assessment would involve multiple methods to verify both structure and function, as proper folding doesn't always guarantee full functionality, especially in membrane proteins like AQP2.

What are the key challenges in expressing and purifying Elephas maximus AQP2?

Researchers working with elephant AQP2 should anticipate several challenges:

  • Tetramer Stability: As observed with human AQP2 mutants, maintaining tetramer stability during purification can be challenging . Size-exclusion chromatography often reveals multiple oligomeric states including monomers, tetramers, and higher-order aggregates. Optimizing buffer conditions (detergent type, concentration, pH, salt concentration) is crucial for preserving the native tetrameric state.

  • Reconstitution Efficiency: Protein incorporation into liposomes can vary significantly between preparations, particularly for less stable constructs . Quantifying protein content in proteoliposomes using Western blot analysis is essential for normalizing functional measurements.

  • Expression Yield Variability: Different constructs may show variable expression levels. For example, certain human AQP2 mutants show significantly lower yields compared to wild-type, possibly due to inherent protein instability .

  • Post-translational Modifications: Ensuring proper glycosylation, which affects protein trafficking and stability, requires careful selection of expression systems that can reproduce mammalian-like modifications.

  • Species-Specific Optimization: Codon optimization for the expression system used may be necessary to maximize yields of elephant AQP2, as codon usage bias between elephants and expression hosts can affect translation efficiency.

Systematic optimization of expression conditions, purification protocols, and stability assessment will be necessary to overcome these challenges when working with elephant AQP2.

What structural features distinguish AQP2 from other aquaporins?

AQP2 shares the general structural architecture of the aquaporin family while possessing distinct features:

  • Homotetrameric Assembly: AQP2 functions as a homotetramer, with each monomer forming an independent water pore . This quaternary structure is essential for proper function and cellular trafficking.

  • Glycosylation Site: AQP2 contains a specific glycosylation site that plays a crucial role in protein quality control and trafficking. Mutations near this site (such as T125M and T126M in human AQP2) can affect protein processing without necessarily disrupting water channel function .

  • Vasopressin-Regulated Trafficking Domains: Unlike some constitutively expressed aquaporins, AQP2 contains specialized domains that respond to vasopressin signaling, enabling dynamic regulation of membrane localization.

  • Selectivity Filter: Like other aquaporins, AQP2 contains the characteristic NPA (asparagine-proline-alanine) motifs that form part of the water selectivity filter, preventing passage of protons while allowing water molecules to pass.

For Elephas maximus AQP2, comparative analysis with human AQP2 would likely reveal evolutionary adaptations possibly related to the elephant's unique water metabolism needs, though the core structural features would likely be conserved given the fundamental importance of water homeostasis across mammalian species.

How do point mutations affect the structure-function relationship of AQP2?

Point mutations in AQP2 can have diverse effects on protein structure and function, providing valuable insights into structure-function relationships:

  • Functional Capacity Despite Structural Alterations: Research on human AQP2 mutations (T125M, T126M, and A147T) associated with nephrogenic diabetes insipidus (NDI) revealed that these proteins retain water permeability despite being disease-causing . These mutants exhibited 74.3%, 92.6%, and 49.9% of wild-type water permeability, respectively, when tested in proteoliposomes . This suggests that disease pathology isn't always due to loss of transport function but can stem from trafficking defects.

  • Local vs. Global Structural Effects: Crystal structures of T125M and T126M mutants (3.9Å and 3.15Å resolution, respectively) showed high structural similarity to wild-type AQP2, indicating that disease-causing mutations may cause subtle local conformational changes rather than global misfolding . These subtle changes can still be detected by cellular quality control systems.

  • Stability Impact: Different mutations affect protein stability to varying degrees. For example, while T125M and T126M showed stability comparable to wild-type AQP2, the A147T mutation significantly decreased protein stability as measured by circular dichroism and nanoDSF . This destabilization likely contributes to its endoplasmic reticulum (ER) retention.

The following table summarizes the functional and stability characteristics of selected human AQP2 mutants, which provides a framework for investigating elephant AQP2 mutations:

MutationWater Permeability (% of wild-type)Tetramer StabilityER RetentionStructure Solved
T125M74.3%HighYes3.9Å resolution
T126M92.6%ModerateYes3.15Å resolution
A147T49.9%LowYesNo

This structure-function analysis approach would be valuable for characterizing naturally occurring or engineered mutations in Elephas maximus AQP2.

What methodologies are most effective for resolving discrepancies in functional studies of AQP2 across different experimental systems?

Researchers have observed significant discrepancies in AQP2 functional studies across experimental systems. To address these inconsistencies, the following methodological approaches are recommended:

  • Complementary System Analysis: Employ multiple experimental systems in parallel to provide convergent evidence. Human AQP2 mutants showed different relative water permeabilities in oocytes versus proteoliposomes - for instance, T125M and T126M showed 25% and 20% permeability in oocytes but 74.3% and 92.6% in proteoliposomes . These differences highlight the importance of not relying on a single system.

  • Isolated System Priority: When discrepancies exist, prioritize data from purified protein in defined systems (proteoliposomes) over cellular systems, as the latter can be influenced by endogenous factors . Proteoliposome studies provide direct measurement of water transport without confounding cellular variables.

  • Standardized Quantification: Implement rigorous protein quantification to normalize functional measurements. Western blot analysis of protein content in proteoliposomes is essential, as reconstitution efficiency can vary significantly between preparations and constructs .

  • Control for Oligomeric State: Assess the quaternary structure distribution (monomers vs. tetramers) immediately prior to functional assays using size-exclusion chromatography, as oligomeric state directly impacts function .

  • Methodological Validation: For novel proteins like elephant AQP2, validate methods using well-characterized aquaporins as positive controls and empty vesicles as negative controls.

When applying these approaches to Elephas maximus AQP2, researchers should systematically document experimental conditions that may contribute to functional variability, including membrane composition, protein:lipid ratios, and buffer conditions.

How can we optimize crystallization conditions for structural studies of Elephas maximus AQP2?

Optimizing crystallization conditions for elephant AQP2 would likely follow principles established for human AQP2, with adaptations for species-specific properties:

  • Detergent Screening: Systematic evaluation of detergents is crucial for membrane protein crystallization. For human AQP2, successful crystallization has been achieved with specific detergents that maintain the protein in a stable, homogeneous state . A primary screen including n-Dodecyl-β-D-Maltopyranoside (DDM), n-Decyl-β-D-Maltopyranoside (DM), and newer detergents like Lauryl Maltose Neopentyl Glycol (LMNG) would be recommended for elephant AQP2.

  • Lipid Supplementation: Specific lipids can stabilize membrane proteins and promote crystal contacts. Consider supplementing crystallization trials with lipids found in elephant kidney membranes or cholesterol, which often stabilizes mammalian membrane proteins.

  • Construct Optimization: Based on human AQP2 studies, consider testing multiple constructs with varying N- and C-terminal boundaries. Terminal flexibility can hinder crystallization, so truncated constructs may improve crystal quality.

  • Stability Assessment: Utilize thermal stability assays (nanoDSF or thiol-reactive dyes) to identify buffer conditions that maximize protein stability . Conditions that enhance thermal stability often improve crystallization outcomes.

  • Crystal Seeding: Once initial crystals are obtained, microseed matrix screening can significantly improve crystal quality. This approach was likely employed for human AQP2 mutant structures, which achieved resolutions of 3.15-3.9Å .

  • Crystallization Space Exploration: Implement sparse matrix screening combined with systematic grid screens around initial hits. For human AQP2 mutants, all constructs crystallized in the same condition as wild-type AQP2, suggesting that similar conditions might work for elephant AQP2 .

Temperature optimization is particularly important, as thermal stability may differ between human and elephant proteins due to adaptations to different body temperatures and environmental conditions.

What insights can comparative analysis of AQP2 across species provide for understanding Elephas maximus AQP2 function?

Comparative analysis of AQP2 across species offers valuable insights for understanding elephant AQP2:

  • Evolutionary Conservation of Critical Domains: By comparing sequence conservation across species, researchers can identify universally conserved residues likely essential for basic water transport versus species-specific adaptations. The NPA motifs and aromatic/arginine (ar/R) constriction region that form the water selectivity filter are typically highly conserved, while regulatory domains may show greater species variation.

  • Species-Specific Adaptations: Elephants have unique water management needs due to their size, habitat, and physiological adaptations. Comparative analysis might reveal adaptations in AQP2 regulatory regions that could relate to elephants' ability to process large water volumes or adapt to seasonal water availability.

  • Thermal Stability Adaptations: Elephants maintain a slightly lower body temperature (approximately 36°C) compared to humans (37°C). Comparative stability studies of AQP2 across species with different body temperatures might reveal adaptations in protein stability related to thermal environment.

  • Trafficking Regulation: Species-specific differences in vasopressin regulation of AQP2 trafficking could provide insights into how water conservation mechanisms have evolved differently in elephants compared to other mammals.

  • Pathological Mutation Analysis: Comparing the effects of equivalent mutations across species can reveal species-specific vulnerability or resilience to functional disruption. For example, if a mutation causing NDI in humans (such as A147T) were introduced to the equivalent position in elephant AQP2, would it show different stability or functional characteristics?

This comparative approach requires generating and analyzing an alignment of AQP2 sequences from diverse mammals, with particular attention to species with different body sizes, habitats, and water conservation needs.

How can we effectively study the role of endoplasmic reticulum quality control in AQP2 processing across species?

Studying endoplasmic reticulum (ER) quality control in AQP2 processing across species requires sophisticated approaches that can be applied to elephant AQP2 research:

  • Heterologous Expression Systems: Utilize species-matched cell lines where possible, or compare multiple cell types (human, elephant-derived if available, and general mammalian lines) to express elephant AQP2. This approach helps distinguish universal from species-specific quality control mechanisms .

  • Glycosylation Pattern Analysis: AQP2 contains a specific glycosylation site that interacts with ER quality control machinery. Mass spectrometry analysis of glycosylation patterns can reveal species-specific differences in processing . Compare wild-type and mutant glycosylation states to identify how structural alterations affect processing.

  • ER Chaperone Interaction Profiling: Use co-immunoprecipitation and proximity labeling techniques to identify species-specific differences in how AQP2 interacts with ER chaperones like calnexin, calreticulin, and UDP-glucose:glycoprotein glucosyltransferase (UGT) .

  • Mutagenesis Studies: Introduce mutations at sites known to affect human AQP2 processing, such as T125M and T126M near the glycosylation site. The research on human AQP2 revealed that T126M created a hydrophobic residue in position 3 relative to the glycosylation site, potentially increasing its recognition by UGT .

  • Chemical Chaperone Rescue Experiments: Test whether chemical chaperones can promote plasma membrane targeting of ER-retained elephant AQP2 mutants, similar to studies with human A147T and T126M mutants . This approach can reveal whether misfolding is minor and potentially correctable.

The following comparative assessment framework could be helpful:

AspectHuman AQP2Elephant AQP2Significance
Glycosylation site sequence context[Documented][To determine]Affects UGT recognition
Response to chemical chaperonesPositive for some mutants[To determine]Indicates correctability
Tetramerization efficiencyVariable by mutant[To determine]Affects ER exit
Half-life in ER[Documented][To determine]Indicates degradation rate

This systematic approach will help elucidate both universal and species-specific aspects of AQP2 quality control.

What are the optimal protocols for extracting and purifying Elephas maximus AQP2 for functional studies?

Based on successful approaches with human AQP2, the following optimized protocol for elephant AQP2 extraction and purification is recommended:

  • Expression System Selection: The baculovirus/insect cell system has demonstrated excellent results for human AQP2, yielding approximately 0.5 mg of pure protein per liter of bioreactor culture . Alternatively, Pichia pastoris has also proven effective for human AQP2 expression . For elephant AQP2, start with these systems, potentially with codon optimization for the selected host.

  • Affinity Tag Design: Incorporate a polyhistidine tag (His-tag) at either the N- or C-terminus for initial affinity purification . Include a TEV protease cleavage site if tag removal is desired for crystallization studies.

  • Cell Lysis and Membrane Preparation:

    • Harvest cells and resuspend in buffer containing protease inhibitors

    • Lyse cells using mechanical disruption (e.g., microfluidizer)

    • Remove cell debris by low-speed centrifugation (5,000 × g, 20 min)

    • Collect membranes by ultracentrifugation (100,000 × g, 1-2 hours)

    • Wash membranes to remove peripheral proteins

  • Solubilization Optimization:

    • Screen detergents including DDM, DM, and LMNG at varying concentrations

    • Typical conditions: 1% detergent, 20 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol

    • Solubilize with gentle agitation for 1-2 hours at 4°C

    • Remove insoluble material by ultracentrifugation (100,000 × g, 30 min)

  • Multi-step Purification:

    • Immobilized metal affinity chromatography (IMAC) using Ni-NTA or TALON resin

    • Size-exclusion chromatography to separate tetramers from monomers and aggregates

    • Optional: Ion exchange chromatography for additional purity

  • Quality Control Assessments:

    • SDS-PAGE and Western blotting to confirm identity and purity

    • Size-exclusion chromatography to verify tetrameric state

    • Circular dichroism spectroscopy to confirm proper folding

    • Mass spectrometry to verify protein integrity and post-translational modifications

  • Stability Optimization:

    • Identify stabilizing additives through thermal stability screening

    • Consider addition of lipids that may stabilize the tetrameric state

This protocol should be systematically optimized for elephant AQP2, with particular attention to detergent selection and buffer composition to maintain the tetrameric assembly crucial for functional studies.

How can we accurately measure water permeability of recombinant Elephas maximus AQP2?

Accurate water permeability measurement of recombinant elephant AQP2 requires rigorous methodology. The following protocol, based on established techniques for human AQP2, provides a comprehensive approach:

  • Proteoliposome Preparation:

    • Reconstitute purified AQP2 into liposomes at defined protein:lipid ratios

    • Include a fluorescent dye (e.g., calcein) inside liposomes for signal detection

    • Control liposomes (without protein) should be prepared identically

    • Verify protein incorporation by Western blot analysis to enable later normalization

  • Stop-Flow Spectroscopy Measurements:

    • Mix proteoliposomes rapidly with hyperosmotic solution in a stop-flow apparatus

    • Monitor fluorescence intensity changes over time (increased fluorescence indicates liposome shrinkage)

    • Perform multiple measurements (≥10) for each sample to ensure statistical reliability

    • Include osmotic gradient controls to verify linear response

  • Data Analysis:

    • Fit a two-exponential function to the fluorescence trace to determine rate constants

    • Calculate osmotic water permeability (Pf) using the equation:
      Pf = k × V0/A × Vw/(ΔOsm × Vw)
      where k is the rate constant, V0 is the initial vesicle volume, A is the vesicle surface area, Vw is the molar volume of water, and ΔOsm is the osmotic gradient

    • Normalize Pf values based on protein content in the liposomes as determined by Western blot quantification

  • Controls and Validations:

    • Empty liposomes serve as negative controls

    • Well-characterized aquaporins (e.g., human AQP1) can serve as positive controls

    • Verify size distribution of proteoliposomes by dynamic light scattering

    • Use mercurial compounds (AQP inhibitors) to confirm specificity of water transport

  • Temperature Considerations:

    • Perform measurements at physiologically relevant temperatures

    • Consider comparing activity at elephant body temperature (~36°C) versus human body temperature (37°C)

The table below illustrates typical results expected based on human AQP2 studies:

SampleNormalized Pf (cm/s)Relative Permeability (%)
Empty liposomes0.076 ± 0.006-
Wild-type AQP20.213 ± 0.004100
Functional mutant0.180-0.20085-95
Compromised mutant0.140-0.16050-75

This methodological approach provides the most direct and quantitative assessment of water channel activity for elephant AQP2.

What are the best approaches for studying AQP2 trafficking and regulation in cellular models relevant to Elephas maximus?

Studying elephant AQP2 trafficking requires both general approaches and species-specific considerations:

  • Cell Model Selection:

    • Primary cultures: Ideally, establish primary kidney collecting duct cells from elephant kidney tissue when ethically available (e.g., from deceased animals in conservation programs)

    • Immortalized cell lines: Develop SV40-transformed elephant kidney cell lines if possible

    • Cross-species models: Evaluate human or other mammalian kidney cell lines (MDCK, mpkCCD) for heterologous expression

    • Transfected cell systems: HEK293 or LLC-PK1 cells expressing elephant AQP2

  • Fluorescent Protein Tagging Strategies:

    • Generate C-terminal GFP/mCherry fusions of elephant AQP2, ensuring the tag doesn't interfere with trafficking signals

    • Create tetracycline-inducible expression systems to control expression levels

    • Implement dual-color approaches to simultaneously track AQP2 and organelle markers

  • Live-Cell Imaging Techniques:

    • Total Internal Reflection Fluorescence (TIRF) microscopy to visualize insertion events at the plasma membrane

    • Spinning disk confocal microscopy for rapid 3D imaging of trafficking dynamics

    • Photoactivatable or photoconvertible tags for pulse-chase visualization of specific protein pools

  • Vasopressin Response Assessment:

    • Dose-response studies with arginine vasopressin (AVP) to evaluate trafficking sensitivity

    • Phosphorylation-specific antibodies to monitor key regulatory sites (development of elephant-specific antibodies may be required)

    • PKA and other kinase inhibitors to dissect signaling pathways

  • Quantitative Analysis Protocols:

    • Plasma membrane to cytoplasmic fluorescence ratio measurements

    • Automated vesicle tracking algorithms to quantify movement parameters

    • FRAP (Fluorescence Recovery After Photobleaching) to measure membrane protein mobility

  • Species-Specific Considerations:

    • Temperature optimization for elephant physiology (approximately 36°C)

    • Evaluation of elephant-specific hormonal regulation patterns

    • Assessment of unique regulatory mechanisms that may have evolved in elephants related to their water conservation adaptations

These approaches should be implemented with appropriate controls, including trafficking-deficient mutants as negative controls and wild-type human AQP2 as a comparative benchmark. The resulting data can provide unique insights into evolutionary conservation and specialization of AQP2 trafficking mechanisms in elephants.

How can we integrate structural and functional data to develop a comprehensive model of Elephas maximus AQP2?

Developing a comprehensive model of elephant AQP2 requires systematic integration of structural and functional data through the following methodological framework:

  • Sequence-Based Structure Prediction:

    • Generate a primary sequence alignment between elephant and human AQP2

    • Identify conserved and divergent regions, especially in functional domains

    • Use homology modeling based on human AQP2 crystal structures to create an initial elephant AQP2 model

    • Refine the model using molecular dynamics simulations in a membrane environment

  • Experimental Structure Determination:

    • X-ray crystallography of purified elephant AQP2 (following methods successful for human AQP2)

    • Cryo-electron microscopy as an alternative approach if crystallization proves challenging

    • Validate structures using small-angle X-ray scattering (SAXS) to confirm solution-state conformation

  • Structure-Function Correlation Studies:

    • Site-directed mutagenesis of key residues identified from structural analysis

    • Functional assessment of mutants using proteoliposome water permeability assays

    • Thermostability measurements (nanoDSF) to correlate structural stability with function

  • Molecular Dynamics Simulations:

    • Simulate water permeation through the channel to calculate theoretical permeability

    • Model conformational changes associated with gating or regulation

    • Identify potential species-specific water interaction sites within the channel

  • Integration Framework:

    • Develop a database linking structural features, mutations, and functional outcomes

    • Implement machine learning approaches to predict functional impacts of structural variations

    • Create interactive visualization tools that link structural elements to functional data

  • Comparative Modeling Across Species:

    • Extend analysis to include other mammalian AQP2 structures

    • Identify structure-function relationships that are universally conserved versus elephant-specific adaptations

The following integrated data table represents the type of comprehensive analysis that would emerge from this approach:

Structural RegionElephant-Specific FeaturesFunctional ImpactEvolutionary Significance
NPA motifs[To be determined]Water selectivityHighly conserved across species
ar/R constriction[To be determined]Pore size regulationPotential adaptations for water throughput
External vestibule[To be determined]Water entry dynamicsPossible adaptation to osmotic challenges
C-terminal domain[To be determined]Trafficking regulationSpecies-specific regulatory mechanisms

This integrated approach would yield not just a static structural model but a dynamic understanding of structure-function relationships in elephant AQP2.

How can researchers effectively differentiate between structural defects and trafficking abnormalities in AQP2 mutant studies?

Differentiating between structural defects and trafficking abnormalities in AQP2 mutants requires a multi-faceted analytical approach:

  • Integrated Structural Assessment Framework:

    • Circular dichroism (CD) spectroscopy to analyze secondary structure integrity

    • Size-exclusion chromatography to evaluate tetrameric assembly

    • Thermal stability measurements (nanoDSF) to quantify folding robustness

    • X-ray crystallography or cryo-EM for high-resolution structural determination when possible

  • Direct Functional Measurements in Cell-Free Systems:

    • Proteoliposome water permeability assays to assess intrinsic channel function independent of trafficking

    • Stopped-flow light scattering to quantify water transport rates

    • Inhibitor sensitivity testing to probe for altered pore structure

  • Cellular Trafficking Analysis:

    • Subcellular fractionation with Western blot analysis

    • Immunofluorescence microscopy with organelle co-localization

    • Surface biotinylation assays to quantify plasma membrane expression

    • Endoglycosidase H sensitivity to assess ER-to-Golgi trafficking

  • Molecular Interaction Studies:

    • Co-immunoprecipitation with ER quality control components (calnexin, BiP)

    • Proximity labeling to identify differential interactomes of wild-type versus mutant proteins

    • Split-ubiquitin assays to assess changes in protein-protein interactions

  • Chemical Rescue Approaches:

    • Chemical chaperone treatment (glycerol, trimethylamine N-oxide) to distinguish correctable from irreversible defects

    • Temperature sensitivity analysis (growth at reduced temperatures)

    • Proteasome inhibition to assess degradation pathways

The following decision matrix helps differentiate between defect types:

ObservationStructural DefectTrafficking AbnormalityMixed Defect
CD spectrumAlteredNormalSlightly altered
Thermal stabilitySignificantly reducedNormal/slightly reducedModerately reduced
Proteoliposome functionReduced/absentNormal/near-normalVariable
ER retentionYesYesYes
Chemical chaperone rescuePoor/noneSignificantPartial
Crystal structureMajor alterationsMinor/no alterationsLocalized alterations

For elephant AQP2 mutants, this systematic approach would not only categorize defects but also provide insights into species-specific quality control mechanisms that may have evolved in response to the unique physiological demands of these large mammals.

How can molecular dynamics simulations enhance our understanding of water transport through Elephas maximus AQP2?

Molecular dynamics (MD) simulations offer powerful insights into water transport through elephant AQP2, complementing experimental approaches:

  • System Setup and Preparation:

    • Generate a high-quality homology model of elephant AQP2 based on human AQP2 crystal structures

    • Embed the tetrameric protein in a physiologically relevant lipid bilayer

    • Solvate the system with explicit water molecules and add appropriate counter-ions

    • Apply a force field optimized for membrane proteins (e.g., CHARMM36, Amber Lipid17)

  • Equilibration and Production Protocols:

    • Implement multi-stage equilibration (minimization, heating, pressure equilibration)

    • Conduct production simulations on microsecond timescales to capture relevant water permeation events

    • Perform multiple independent simulations to improve statistical sampling

    • Apply enhanced sampling techniques (umbrella sampling, metadynamics) for energy barrier calculations

  • Water Transport Analysis:

    • Track individual water molecule trajectories through the channel

    • Calculate osmotic permeability coefficients (pf) and diffusive permeability coefficients (pd)

    • Identify rate-limiting steps in the water permeation pathway

    • Compare computed permeability with experimental measurements

  • Structural Dynamics Assessment:

    • Analyze conformational fluctuations of key residues lining the water pore

    • Evaluate hydrogen-bonding networks critical for water orientation

    • Identify potential gating mechanisms and conformational changes

    • Calculate free energy profiles for water transport along the channel axis

  • Comparative Simulations:

    • Compare elephant AQP2 dynamics with human AQP2 under identical simulation conditions

    • Introduce species-specific mutations to identify functionally important differences

    • Simulate disease-causing mutations to understand their molecular impact

    • Model the effects of potential inhibitors specific to elephant AQP2

The following data can typically be extracted from MD simulations:

These simulations provide a molecular-level understanding of water transport mechanisms that cannot be directly observed experimentally, offering unique insights into how evolutionary adaptations in elephant AQP2 may optimize water transport for their specific physiological needs.

What are the current knowledge gaps and future research directions for Elephas maximus AQP2?

The study of Elephas maximus AQP2 represents an emerging field with significant knowledge gaps that present exciting research opportunities. Based on our analysis of available information and extrapolation from human AQP2 research, several critical areas for future investigation emerge.

Key knowledge gaps include: (1) the absence of experimentally determined structures for elephant AQP2; (2) limited understanding of species-specific regulatory mechanisms; (3) unclear evolutionary adaptations that may optimize water conservation in elephants; and (4) insufficient characterization of trafficking dynamics in elephant kidney cells. Additionally, the relationship between elephant AQP2 and their unique physiological demands remains largely unexplored.

Future research should prioritize: expression and purification of recombinant elephant AQP2; structural determination through X-ray crystallography or cryo-EM; comparative functional analysis with human AQP2; and investigation of regulatory mechanisms specific to elephant physiology . Development of elephant kidney cell lines or organoids would significantly advance our understanding of species-specific trafficking dynamics. The potential for discovering novel regulatory mechanisms adapted to the elephant's water management needs represents an exciting frontier that could provide insights into evolutionary adaptations to diverse environmental conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.